These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15993596)

  • 41. Bradykinin receptor antagonists--a review of the patent literature 2005-2008.
    Fincham CI; Bressan A; Paris M; Rossi C; Fattori D
    Expert Opin Ther Pat; 2009 Jul; 19(7):919-41. PubMed ID: 19552510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of acute nociceptive responses in rat spinal cord by a bradykinin B1 receptor antagonist.
    Conley RK; Wheeldon A; Webb JK; DiPardo RM; Homnick CF; Bock MG; Chen TB; Chang RS; Pettibone DJ; Boyce S
    Eur J Pharmacol; 2005 Dec; 527(1-3):44-51. PubMed ID: 16310181
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural modification of the highly potent peptide bradykinin B1 receptor antagonist B9958.
    Gera L; Stewart JM; Fortin JP; Morissette G; Marceau F
    Int Immunopharmacol; 2008 Feb; 8(2):289-92. PubMed ID: 18182242
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel 2-aminopyrimidine carbamates as potent and orally active inhibitors of Lck: synthesis, SAR, and in vivo antiinflammatory activity.
    Martin MW; Newcomb J; Nunes JJ; McGowan DC; Armistead DM; Boucher C; Buchanan JL; Buckner W; Chai L; Elbaum D; Epstein LF; Faust T; Flynn S; Gallant P; Gore A; Gu Y; Hsieh F; Huang X; Lee JH; Metz D; Middleton S; Mohn D; Morgenstern K; Morrison MJ; Novak PM; Oliveira-dos-Santos A; Powers D; Rose P; Schneider S; Sell S; Tudor Y; Turci SM; Welcher AA; White RD; Zack D; Zhao H; Zhu L; Zhu X; Ghiron C; Amouzegh P; Ermann M; Jenkins J; Johnston D; Napier S; Power E
    J Med Chem; 2006 Aug; 49(16):4981-91. PubMed ID: 16884310
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [2-aminodihydropyridines / Structure and antihypertensive activity (author's transl)].
    Meyer H; Wehinger E; Bossert F; Stoepel K; Vater W
    Arzneimittelforschung; 1981; 31(8):1173-7. PubMed ID: 7197524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potent and orally bioavailable non-peptide antagonists at the human bradykinin B(1) receptor based on a 2-alkylamino-5-sulfamoylbenzamide core.
    Ritchie TJ; Dziadulewicz EK; Culshaw AJ; Müller W; Burgess GM; Bloomfield GC; Drake GS; Dunstan AR; Beattie D; Hughes GA; Ganju P; McIntyre P; Bevan SJ; Davis C; Yaqoob M
    J Med Chem; 2004 Sep; 47(19):4642-4. PubMed ID: 15341478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bradykinin B1 receptor antagonists: a patent update 2009 - 2012.
    Bozó É; Éles J; Keserű GM
    Expert Opin Ther Pat; 2012 Dec; 22(12):1443-52. PubMed ID: 23033970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 2-aryloxy-4-alkylaminopyridines: discovery of novel corticotropin-releasing factor 1 antagonists.
    Chen YL; Obach RS; Braselton J; Corman ML; Forman J; Freeman J; Gallaschun RJ; Mansbach R; Schmidt AW; Sprouse JS; Tingley Iii FD; Winston E; Schulz DW
    J Med Chem; 2008 Mar; 51(5):1385-92. PubMed ID: 18288792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quinolinyl- and phenantridinyl-acetamides as bradykinin B1 receptor antagonists.
    Eles J; Beke G; Vágó I; Bozó E; Huszár J; Tarcsay A; Kolok S; Schmidt E; Vastag M; Hornok K; Farkas S; Domány G; Keserű GM
    Bioorg Med Chem Lett; 2012 May; 22(9):3095-9. PubMed ID: 22483585
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blockade of bradykinin B2 receptor more effectively reduces postischemic blood-brain barrier disruption and cytokines release than B1 receptor inhibition.
    Su J; Cui M; Tang Y; Zhou H; Liu L; Dong Q
    Biochem Biophys Res Commun; 2009 Oct; 388(2):205-11. PubMed ID: 19647718
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of B1 bradykinin receptors in the kindled hippocampus increases extracellular glutamate levels: a microdialysis study.
    Mazzuferi M; Binaschi A; Rodi D; Mantovani S; Simonato M
    Neuroscience; 2005; 135(3):979-86. PubMed ID: 16125864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bradykinin B1 receptor antagonists as potential therapeutic agents for pain.
    Huang H; Player MR
    J Med Chem; 2010 Aug; 53(15):5383-99. PubMed ID: 20369879
    [No Abstract]   [Full Text] [Related]  

  • 53. Discovery and pharmacological evaluation of growth hormone secretagogue receptor antagonists.
    Xin Z; Serby MD; Zhao H; Kosogof C; Szczepankiewicz BG; Liu M; Liu B; Hutchins CW; Sarris KA; Hoff ED; Falls HD; Lin CW; Ogiela CA; Collins CA; Brune ME; Bush EN; Droz BA; Fey TA; Knourek-Segel VE; Shapiro R; Jacobson PB; Beno DW; Turner TM; Sham HL; Liu G
    J Med Chem; 2006 Jul; 49(15):4459-69. PubMed ID: 16854051
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of the critical residues of bradykinin receptor B1 for interaction with the kinins guided by site-directed mutagenesis and molecular modeling.
    Ha SN; Hey PJ; Ransom RW; Bock MG; Su DS; Murphy KL; Chang R; Chen TB; Pettibone D; Hess JF
    Biochemistry; 2006 Dec; 45(48):14355-61. PubMed ID: 17128974
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vascular B1 kinin receptors in patients with congestive heart failure.
    Lang NN; Cruden NL; Tse GH; Bloomfield P; Ludlam CA; Fox KA; Newby DE
    J Cardiovasc Pharmacol; 2008 Nov; 52(5):438-44. PubMed ID: 19033823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and structure-activity relationships of piperidine-based melanin-concentrating hormone receptor 1 antagonists.
    Wu WL; Burnett DA; Spring R; Qiang L; Sasikumar TK; Domalski MS; Greenlee WJ; O'Neill K; Hawes BE
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3668-73. PubMed ID: 16690312
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of a dual-function peptide that combines aminopeptidase N inhibition and kinin B1 receptor antagonism.
    Gera L; Fortin JP; Adam A; Stewart JM; Marceau F
    J Pharmacol Exp Ther; 2006 Apr; 317(1):300-8. PubMed ID: 16368899
    [TBL] [Abstract][Full Text] [Related]  

  • 58. B1 and TRPV-1 receptor genes and their relationship to hyperalgesia following spinal cord injury.
    DomBourian MG; Turner NA; Gerovac TA; Vemuganti R; Miranpuri GS; Türeyen K; Satriotomo I; Miletic V; Resnick DK
    Spine (Phila Pa 1976); 2006 Nov; 31(24):2778-82. PubMed ID: 17108828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression and functional pharmacology of the bradykinin B1 receptor in the normal and inflamed human gallbladder.
    Andre E; Gazzieri D; Bardella E; Ferreira J; Mori MA; Saul VV; Bader M; Calixto JB; De Giorgio R; Corinaldesi R; Geppetti P; Trevisani M
    Gut; 2008 May; 57(5):628-33. PubMed ID: 18182589
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of kinin B1 receptors in the nociception produced by peripheral protein kinase C activation in mice.
    Ferreira J; Trichês KM; Medeiros R; Cabrini DA; Mori MA; Pesquero JB; Bader M; Calixto JB
    Neuropharmacology; 2008 Mar; 54(3):597-604. PubMed ID: 18164734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.